Cancer Biology is a major focal point for disease-specific scientific research at the University of Chicago, which has its medical school and clinical programs integrated within the Biological Sciences Division on a single, compact campus. Since the last CBTG renewal, the Cancer Biology Training Program (CBTP) has matured and flourished under the auspices of the Committee on Cancer Biology (CCB). The program supports six postdoctorates and has grown from 6 to 31 predoctoral students since 1997, when the formal degree-granting program in Cancer Biology was initiated. The 42 faculty trainers involved in the CBTG are among the most distinguished and productive researchers In the Division of Biological Sciences. Moreover, the development of the CCB has facilitated the recruitment of both junior and senior faculty members whose major focus is cancer-oriented research. The existence of the CCB has also led to a substantial increase in the number of students and postdoctorates interested in cancer biology on campus. Cancer Biology is now recognized as one of the premier predoctoral and postdoctoral training programs in the Division and ranks among the best cancer biology programs in the country. The Committee on Cancer Biology draws much of its strength from its interdepartmental relationships, allowing trainees to supplement advanced training in Cancer Biology with basic training in one of many scientific disciplines, including molecular genetics, molecular biology, cell biology, biochemistry, human genetics, immunology, microbiology, epidemiology, developmental biology, genetics, health studies, radiology and radiation biology. As such, trainees share a common interest and expertise in cancer research but have academic and research skills in the wide range of fields necessary to pursue state-of-the-art cancel research. All trainees have extensive opportunity for specialized training in cancer biology through core courses, seminars, symposia, an annual retreat, workshops, journal clubs, group meetings and poster sessions, as well as interactions with seminar and symposia speakers. Collectively, the CBTP offers graduate students and postdoctoral trainees a broad and intensive training intended to foster and strengthen their interest in a scientific career in Cancer Biology.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Institutional National Research Service Award (T32)
Project #
Application #
Study Section
Subcommittee G - Education (NCI)
Program Officer
Damico, Mark W
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Chicago
Internal Medicine/Medicine
Schools of Medicine
United States
Zip Code
Savage, Peter A; Leventhal, Daniel S; Malchow, Sven (2014) Shaping the repertoire of tumor-infiltrating effector and regulatory T cells. Immunol Rev 259:245-58
Mason, Jennifer M; Logan, Hillary L; Budke, Brian et al. (2014) The RAD51-stimulatory compound RS-1 can exploit the RAD51 overexpression that exists in cancer cells and tumors. Cancer Res 74:3546-55
Isikbay, Masis; Otto, Kristen; Kregel, Steven et al. (2014) Glucocorticoid receptor activity contributes to resistance to androgen-targeted therapy in prostate cancer. Horm Cancer 5:72-89
Wheeler, Heather E; Aquino-Michaels, Keston; Gamazon, Eric R et al. (2014) Poly-omic prediction of complex traits: OmicKriging. Genet Epidemiol 38:402-15
Moen, Erika L; Stark, Amy L; Zhang, Wei et al. (2014) The role of gene body cytosine modifications in MGMT expression and sensitivity to temozolomide. Mol Cancer Ther 13:1334-44
Gamazon, Eric R; Lamba, Jatinder K; Pounds, Stanley et al. (2013) Comprehensive genetic analysis of cytarabine sensitivity in a cell-based model identifies polymorphisms associated with outcome in AML patients. Blood 121:4366-76
Budke, Brian; Kalin, Jay H; Pawlowski, Michal et al. (2013) An optimized RAD51 inhibitor that disrupts homologous recombination without requiring Michael acceptor reactivity. J Med Chem 56:254-63
Reyes, Edwin E; Kunovac, Stefan K; Duggan, Ryan et al. (2013) Growth kinetics of CD133-positive prostate cancer cells. Prostate 73:724-33
Wheeler, Heather E; Maitland, Michael L; Dolan, M Eileen et al. (2013) Cancer pharmacogenomics: strategies and challenges. Nat Rev Genet 14:23-34
Budke, Brian; Chan, Yuen-Ling; Bishop, Douglas K et al. (2013) Real-time solution measurement of RAD51- and RecA-mediated strand assimilation without background annealing. Nucleic Acids Res 41:e130

Showing the most recent 10 out of 57 publications